Treatment of Patients with ALK-positive Non-small Cell Lung Cancer and Brain Metastases
Background and objective Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) is an important subtype of lung cancer. The standard modality of ALK-positive NSCLC with brain metastases remains uncertain. Methods We collected data on clinical characteristics and treatment of pa...
Main Authors: | Jialin LV, Quan ZHANG, Na QIN, Xinjie YANG, Xinyong ZHANG, Yuhua WU, Xi LI, Hui ZHANG, Jinghui WANG, Shucai ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2016-08-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.06 |
Similar Items
-
Genetic profiling of circulating cell‐free DNA from cerebrospinal fluid and paired plasma in ALK‐positive lung cancer with brain metastases
by: Liang Shi, et al.
Published: (2023-07-01) -
Clinical Efficacy of Crizotinib in Advanced ALK Positive
Non-small Cell Lung Cancer
by: Jing ZHAO, et al.
Published: (2015-10-01) -
A Case of Advanced Lung Squamous Cell Carcinoma with CLIP1-ALK Fusion Gene
by: Yue YUAN, et al.
Published: (2022-09-01) -
Research Progress of Targeted Therapy for Anaplastic Lymphoma Kinase and Other Rare Driver Genes in Advanced Non-small Cell Lung Cancer
by: Quan ZHANG, et al.
Published: (2017-01-01) -
Efficacy and Safety of Crizotinib in Advanced or Recurrent
ALK-positive Non-small Cell Lung Cancer
by: Xiaoyan LI, et al.
Published: (2019-08-01)